|
1 |
15 05 2026 |
Sales of products produced under PLI scheme for pharma exceeded target: DoP |
Pharmabiz |
India |
|
2 |
15 05 2026 |
Indian pharma must diversify logistics routes & strengthen inventory to build long-term resilience: Experts |
Pharmabiz |
India |
|
3 |
15 05 2026 |
CDSCO cancels import registration of skin care cosmetic product Elementre - MD Peel-Tri AHA |
Pharmabiz |
India |
|
4 |
15 05 2026 |
Complex generics are driving Indian pharma’s high-margin future in 2026: Experts |
Pharmabiz |
India |
|
5 |
15 05 2026 |
Drug regulator drafts guidelines on high-risk solvents after tainted syrup death in Kids |
Health world (Economic Times) |
India |
|
6 |
15 05 2026 |
Indoco Remedies clears Malta Medicines Authority audit |
Express Pharma |
India |
|
7 |
15 05 2026 |
Roche Pharma India has announced the launch of Tecentriq® (atezolizumab) SC in India |
Health world (Economic Times) |
India |
|
8 |
15 05 2026 |
Kazakhstan and Türkiye expand cooperation in pharmaceuticals and digital technologies |
Qazinform |
Kazakhstan |
|
9 |
15 05 2026 |
Pharma companies prepare for FDA reset after Makary departure |
Emarker |
USA |
|
10 |
14 05 2026 |
Indian regulators tighten drug quality oversight as substandard and spurious medicine cases rise in five years |
Pharmabiz |
India |
|
11 |
14 05 2026 |
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion |
Silicon India |
India |
|
12 |
14 05 2026 |
Indian pharma firms flood west Africa with powerful opioids despite crackdown: AFP investigation |
Economic Times |
India |
|
13 |
14 05 2026 |
Weight-loss drug semaglutide set to get cheaper as generic wave builds in India |
Health world (Economic Times) |
India |
|
14 |
14 05 2026 |
Zydus Life acquires US-based Assertio for $166 million cash |
Health world (Economic Times) |
India |
|
15 |
14 05 2026 |
Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push |
Indian Pharma Post |
India |
|
16 |
14 05 2026 |
CDSCO cancels registration of 'Elementre-MD Peel -Tri AHA' over safety misleading claim concerns |
Medical Dialogues |
India |
|
17 |
14 05 2026 |
Panel recommends CDSCO to develop uniform mechanism to handle misleading ads of Ayush products |
Pharmabiz |
India |
|
18 |
14 05 2026 |
OneSource Specialty Pharma Board Decides Against Pursuing Composite Merger Scheme in Current Form |
Scan x Trade |
India |
|
19 |
14 05 2026 |
USFDA chief Marty Makary resigns amid Trump clash over flavoured Vape drug decisions |
Medical Dialogues |
USA |
|
20 |
13 05 2026 |
Generic entry triggers explosive growth in India’s GLP-1 agonist market during April 2026 |
Pharmabiz |
India |
